➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Medtronic
AstraZeneca
Boehringer Ingelheim
Moodys

Last Updated: January 24, 2021

DrugPatentWatch Database Preview

Litigation Details for AstraZeneca AB v. Zydus Pharmaceuticals (USA) Inc. (D. Del. 2018)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

AstraZeneca AB v. Zydus Pharmaceuticals (USA) Inc. (D. Del. 2018)

Docket   Start Trial Date Filed 2018-05-01
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand None Referred To
Parties ZYDUS PHARMACEUTICALS (USA) INC.
Patents 6,414,126; 6,515,117; 7,851,502; 7,919,598; 8,221,786; 8,361,972; 8,501,698; 8,685,934; 8,716,251
Attorneys Christopher J. Cassella
Firms Phillips, McLaughlin & Hall, P.A.
Link to Docket External link to docket
Small Molecule Drugs cited in AstraZeneca AB v. Zydus Pharmaceuticals (USA) Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for AstraZeneca AB v. Zydus Pharmaceuticals (USA) Inc. (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
2018-06-22 11 Patent/Trademark Report to Commissioner of Patents the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,851,502 ;7,919,598 ;8,221,786… 1 May 2018 1:18-cv-00664 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2019-01-24 33 Without Prejudice All Claims Concerning U.S. Patent Nos. 7,851,502, 7,919,598, 8,221,786, 8,361,972, 8,501,… 1 May 2018 1:18-cv-00664 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2019-01-27 34 Without Prejudice All Claims Concerning U.S. Patent Nos. 7,851,502, 7,919,598, 8,221,786, 8,361,972, 8,501,… 1 May 2018 1:18-cv-00664 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2019-03-13 37 Complaint - Amended expiration of U.S. Patent Nos. 6,414,126 (“the ’126 patent”) 6,515,117 (“the ’117 patent”), and 8,685,934… This is an action for patent infringement arising under the patent laws of the United States, … FIRST COUNT FOR PATENT INFRINGEMENT (’126 PATENT) 17. AstraZeneca realleges… 18. The U.S. Patent and Trademark Office (“PTO”) issued the ’126 patent on July 2, 2002, entitled… The ’126 patent expires on October 4, 2020, excluding any pediatric exclusivity or patent term extension External link to document
2019-03-14 38 Patent/Trademark Report to Commissioner of Patents the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,414,126 ;6,515,117 ;8,685,934… 1 May 2018 1:18-cv-00664 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2018-05-01 4 Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,614,126 ;6,515,117. (crb) (Entered… 1 May 2018 1:18-cv-00664 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2019-10-11 70 Notice of Service Claim Construction of Certain Terms of U.S. Patent Nos. 6,414,126 and 6,515,117 filed by AstraZeneca AB.(Silver… 1 May 2018 1:18-cv-00664 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
McKesson
Boehringer Ingelheim
Express Scripts
Medtronic
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.